Semaglutide vs Tirzepatide: Key Differences Explained

Educational content, reviewed for accuracy against published clinical literature. Not medical advice.

If you are taking a GLP-1 medication or considering one, you have likely heard of semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). While both are effective for weight management, they work somewhat differently. Here is what the research shows.

How They Work

Semaglutide is a GLP-1 receptor agonist. It mimics the GLP-1 hormone your body naturally produces, which:

• Slows stomach emptying
• Signals fullness to your brain
• Helps regulate blood sugar

Tirzepatide is a dual GLP-1/GIP receptor agonist. It mimics two hormones:

• GLP-1 (same as semaglutide)
• GIP (glucose-dependent insulinotropic polypeptide)

The dual action appears to provide additional benefits for appetite suppression and metabolic function.

Weight Loss Comparison

Head-to-head research shows tirzepatide produces greater average weight loss:

The SURMOUNT-5 trial directly compared them and found tirzepatide achieved about 6.5 percentage points more weight loss than semaglutide.

Side Effect Differences

Both medications cause similar side effects, primarily gastrointestinal:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• These typically improve over time for both medications.

Notable differences:

• In semaglutide trials, gallbladder-related events (mainly gallstones) were more common than with placebo
• A 2025 meta-analysis of 55 randomized trials found GLP-1 medications as a class modestly increase gallstone risk (about 2 extra cases per 1,000 people), and rapid weight loss itself is a known gallstone risk factor regardless of medication
• Overall discontinuation rates due to side effects were similar (roughly 6% to 7%) in head-to-head data

Body Composition

Substudies suggest possible differences in body composition outcomes:

• Both medications reduce fat mass, but some lean mass can also be lost during substantial weight loss
• Body-composition substudies were conducted in different trials using different populations and methods, so they should not be used to claim that one medication reliably preserves more muscle than the other

For either medication, adequate protein intake and resistance training are important strategies for supporting lean mass during weight loss.

Important Note

This information is educational. The choice between medications depends on many individual factors and should be made with your healthcare provider.

How Blum Helps

• Injection log records your specific medication, dose, and timing so your history is always at hand
• Weight trends show your personal response regardless of which medication you’re taking
• Side effect log documents your experience on each medication
• Provider Report Export turns your injections, weight, and side effects into a report your provider can actually use in medication discussions

Key Takeaways

• Semaglutide targets one hormone (GLP-1); tirzepatide targets two (GLP-1 and GIP)
• Tirzepatide produces about 5% to 7% more weight loss on average
• Side effect profiles are similar; gallstone risk is somewhat elevated with GLP-1s as a class
• Both medications can reduce fat mass while some lean mass is also lost; direct muscle-preservation comparisons are limited
• Both are effective options; choice depends on individual factors
• Talk to your healthcare provider if you have questions about which medication might be right for you, or if you are considering switching medications.
• This is general educational information. Please discuss your specific situation with your healthcare provider.

Sources

1. Aronne LJ et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). NEJM 2025. https://www.nejm.org/doi/full/10.1056/NEJMoa2416394
2. Chiang CH et al. Glucagon-Like Peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: A Systematic Review and Meta-Analysis. Gastroenterology 2025. https://pubmed.ncbi.nlm.nih.gov/40499738/

Related Articles

• Switching GLP-1 Medications: What the Transition Involves
• GLP-1 Side Effects: The Complete Overview
• GLP-1 Weight Loss Timeline: What to Expect Month by Month

This article is general educational information about GLP-1 medications and is not medical advice. It does not replace guidance from your prescriber or pharmacist. Always follow your healthcare provider’s instructions, and contact them about any symptom that is severe, persistent, or concerning.